公司概覽
業務類別 Medical Instruments & Supplies
業務概覽 Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%,and 19% of revenue, respectively.
公司地址 41 Seyon Street, Building 1, Suite 100, Waltham, MA, USA, 02453
電話號碼 +1 781 250-0111
傳真號碼 +1 781 250-0115
公司網頁 https://www.repligen.com
員工數量 2000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Ralf Kuriyel, PhD Senior Vice President, Research and Development 美元 420.55K 02/04/2026
Mr. Jason K. Garland Chief Financial Officer 美元 566.50K 02/04/2026
Mr. James R. Bylund Chief Operating Officer 美元 481.20K 02/04/2026
Ms. Violetta A. Hughes Chief Accounting Officer -- 26/02/2026
Mr. Olivier Loeillot Director, President and Chief Executive Officer 美元 860.00K 02/04/2026
Mr. Brian Robb Douglass Senior Vice President and Chief Product Officer 美元 417.15K 02/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Glenn P. Muir Independent Director 02/04/2026
Mr. Nicolas M. Barthelemy Independent Director 02/04/2026
Dr. Martin D. Madaus,PhD Chairman of the Board 06/01/2026
Ms. Carrie Eglinton Manner Independent Director 02/04/2026
Dr. Rohin Mhatre, PhD Independent Director 02/04/2026
Dr. Konstantin Konstantinov, PhD Independent Director 02/04/2026
Mr. Olivier Loeillot Director, President and Chief Executive Officer 02/04/2026
Ms. Margaret A. Pax Independent Director 02/04/2026
 
所屬ETF (更新日期: 14/11/2026 04:11)
代號 名稱 佔比% ▼ 持有日期
SSMGVirtus Silvant Small/Mid Growth ETF0.0003%30/10/2026
RILAIndexperts Gorilla Aggressive Growth ETF0.0003%30/10/2026
DXUVDimensional US Vector Equity ETF0.0003%24/09/2026
TMIDT. Rowe Price Mid-Cap Equity ResearchETF0.0003%31/10/2026
HXEMast HedgeIndex Adaptive Equities ETF0.0003%30/10/2026
MMTMState Street® SPDR® S&P® 1500MomtTiltETF0.0003%30/10/2026
AVTMAvantis Total Equity Markets ETF0.0003%30/10/2026
MFUSPIMCO RAFI Dyn Multi-Factor US Eq ETF0.0003%30/10/2026
SMDXIntech S&P Small-Mid Cap Divers Alp ETF0.0002%30/10/2026
AVSUAvantis Responsible US Equity ETF0.0002%30/10/2026
STXGStrive 1000 Growth ETF0.0002%30/10/2026
RADDAB US Research Advanced ETF0.0002%30/10/2026
SQLTIshares MSCI USA Small-Cap Qul Fac ETF0.0002%30/10/2026
AVMCAvantis U.S. Mid Cap Equity ETF0.0002%30/10/2026
MIDEXtrackers S&P MidCap 400 Scrd & Scrn ETF0.0001%29/10/2026
MFMOMotley Fool Momentum Factor ETF0.0001%30/10/2026
EBILongview Advantage ETF0.0001%30/10/2026
MNZLManzil Russell Halal USA Broad MarketETF0.0001%30/10/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.00004%30/10/2026
ONEOStt Strt® SPDR® Russell 1000 Momt FocETF0.00003%30/10/2026
  1    2    3    4    5    6   7    8    9    10  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.